People Background Check
Find People:

Winston A Vadino, Age 819 Glenmont Rd, White House Station, NJ 08889

Get Report
Known as:
Winston Dr Vadino Winston Andre Vadino Winston F Vadino Andre Vadino Winston
Related to:
Andy Vadino

Winston Vadino Phones & Addresses

9 Glenmont Rd, Whitehouse Station, NJ 08889 (908) 534-9355

White House Station, NJ

Cresco, PA

Bridgewater, NJ

Canadensis, PA

9 Glenmont Rd, Whitehouse Station, NJ 08889

Mentions for Winston A Vadino

Career records & work history

License Records

Winston Andre Vadino

Address:
Whitehouse Station, NJ 08889
Licenses:
License #: RP026201L - Expired
Category: Pharmacy
Type: Pharmacist

Publications & IP owners

Us Patents

Orally Administrable Solid Dosage Form

US Patent:
6335032, Jan 1, 2002
Filed:
Mar 6, 2000
Appl. No.:
09/518871
Inventors:
Stephen M. Liebowitz - Neshanic Station NJ
Elliot I. Stupak - West Caldwell NJ
Imtiaz A. Chaudry - North Caldwell NJ
Winston A. Vadino - Whitehouse Station NJ
Frank E. Bowen - Rutherford NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 948
US Classification:
424451, 424452, 424461, 514383, 514384
Abstract:
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0. 6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.

Orally Administrable Solid Ribavirin Dosage Forms And Process For Making Them

US Patent:
6337090, Jan 8, 2002
Filed:
Nov 13, 2000
Appl. No.:
09/582060
Inventors:
Stephen M. Liebowitz - Neshanic Station NJ
Elliot I. Stupak - West Caldwell NJ
Imtiaz A. Chaudry - North Caldwell NJ
Winston A. Vadino - Whitehouse Station NJ
Frank E. Bowen - Rutherford NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 948
US Classification:
424451, 424452, 424461, 514383, 514384
Abstract:
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0. 6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin and a process for making such solid dosage forms are disclosed.

Controlled Release Dosage Forms Comprising Hydroxypropylmethylcellulose

US Patent:
4695591, Sep 22, 1987
Filed:
Nov 22, 1985
Appl. No.:
6/801130
Inventors:
Gayda Hanna - Berwyn PA
Winston A. Vadino - Bridgewater NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3174
A61K 920
A61K 922
US Classification:
514781
Abstract:
Controlled release solid dosage forms comprising less than about one-third of the total dosage form weight of hydroxypropylmethylcellulose USP 2910 are disclosed.

Sustained Release Labetalol Tablets

US Patent:
4940580, Jul 10, 1990
Filed:
Feb 2, 1989
Appl. No.:
7/306253
Inventors:
Surendra Sangekar - New York NY
Winston A. Vadino - Whitehouse Station NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3179
A01N 3736
US Classification:
424 80
Abstract:
A sustained release dosage form of labetalol hydrochloride is disclosed comprising the active ingredient in a polymeric matrix of hydroxypropylmethylcellulose and polyvinylpyrrolidone and a pharmaceutically acceptable organic acid.

Oral Antifungal Composition

US Patent:
5846971, Dec 8, 1998
Filed:
Jun 20, 1997
Appl. No.:
8/879928
Inventors:
Surendra A. Sangekar - Union NJ
Winston A. Vadino - Whitehouse Station NJ
Ping I. Lee - Radnor PA
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31495
A61K 31675
A61K 3154
A61K 31535
US Classification:
514252
Abstract:
A pharmaceutical composition comprising: i) substantially inert beads; wherein said beads are coated with ii) an antifungal agent which is (-)-(2R-cis)-4-�4-�4-�4-��-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-tr iazol-1-ylmethyl)furan-3-yl!methoxy!phenyl!-1-piperazinyl!phenyl!-2,4-dihyd ro-2-�(S)-1-ethyl-2(S)-hydroxypropyl!-3H-1,2,4-triazol-3-one; iii) a binder to enables the antifungal compound to adhere to said beads. The composition enables the antifungal compound, which has very low water solubility, to have enhanced bioavailability in mammals, such as humans.

Orally Administrable Solid Dosage Form

US Patent:
6051252, Apr 18, 2000
Filed:
May 7, 1999
Appl. No.:
9/307008
Inventors:
Stephen M. Liebowitz - Neshanic Station NJ
Elliot I. Stupak - West Caldwell NJ
Imtiaz A. Chaudry - North Caldwell NJ
Winston A. Vadino - Whitehouse Station NJ
Frank E. Bowen - Rutherford NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 920
A61K 948
A61K 4700
US Classification:
424452
Abstract:
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0. 6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is subsantially free of polymorphic forms of ribavirin is disclosed.

Antifungal Composition With Enhanced Bioavailability

US Patent:
5834472, Nov 10, 1998
Filed:
May 21, 1997
Appl. No.:
8/861250
Inventors:
Surendra A. Sangekar - Union NJ
Winston A. Vadino - Whitehouse Station NJ
Ping I. Lee - Radnor PA
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3150
A61K 31495
US Classification:
514252
Abstract:
A pharmaceutical composition comprising: i) an antifungal agent which is (-)-(2R-cis)-4-�4-�4-�4-��-5-(2,4-difluorophenyl)-tetrahydro-5-(1H-1,2,4-t riazol-1-ylmethyl)furan-3-yl!methoxy!phenyl!-1-piperazinyl!phenyl!-2,4-dihy dro-2-�(S)-1-ethyl-2(S)-hydroxypropyl!-3H-1,2,4-triazol-3-one; ii) at least one non-ionic surfactant; and iii) a diluent. The composition enables the antifungal compound, which has very low water solubility, to have enhanced bioavailability in mammals, such as humans.

Controlled Release Dosage Form Comprising Acetaminophen, Pseudoephedrine Sulfate And Dexbrompheniramine Maleate

US Patent:
4601894, Jul 22, 1986
Filed:
Mar 29, 1985
Appl. No.:
6/718036
Inventors:
Gayda Hanna - Berwyn PA
Winston A. Vadino - Bridgewater NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 922
A61K 926
US Classification:
424 19
Abstract:
The invention relates to a controlled release dosage form comprising three actives: acetaminophen, psueudoephedrine sulfate and dexbrompheniramine maleate.

Possible Relatives

Winston A Johnson  Winston C Stanley  Winston L Jordan  Winston L Mckenzie  Winston Kelley  Winston L Kennedy  Winston S Stephens  Winston C Kyle  Winston T Lewis  Winston D Wiley 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.